MLR-1023
SIGMA/SML0371 - ≥98% (HPLC)
Synonym: 5-(3-Methylphenoxy)- 2(1H)-pyrimidinone; CP 26154; NSC 314335; Tolimidone
CAS Number: 41964-07-2
Empirical Formula (Hill Notation): C11H10N2O2
Molecular Weight: 202.21
MDL Number: MFCD00866900
Linear Formula: C11H10N2O2
Product Type: Chemical
assay | ≥98% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C11H10N2O2/c1-8-3-2-4- |
InChI key | HJQILFPVRNHTIG-UHFFFAOYSA |
Quality Level | 100 ![]() |
SMILES string | Cc1cccc(OC2=CNC(=O)N=C2)c |
solubility | DMSO: 15 mg/mL (clear solution) |
storage temp. | room temp |
Biochem/physiol Actions: | MLR-1023 has a therapeutic potential to treat type 2 diabetes. |
Biochem/physiol Actions: | MLR-1023 is a potent, orally active, allosteric activator of the non-receptor Src-related Lyn kinase that produces lasting glucose lowering, reduces HbA1c levels, and preserves pancreatic β-cells in db/db mice. MLR-1023 increased insulin receptor sensitivity. MLR-1023 (Tolimidone) is antiulcer agent. |
Features and Benefits: | This compound is a featured product for Kinase Phosphatase Biology research. Click here ![]() ![]() |
Features and Benefits: | This compound is featured on the InsR ![]() ![]() |
Packaging: | 5, 25 mg in glass bottle |
Symbol | ![]() |
Signal word | Warning |
Hazard statements | H319 |
Precautionary statements | P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36 |
Safety Statements | 26 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | room temp |
UNSPSC | 12352200 |